Cargando…

Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis

BACKGROUND: It is unknown whether nitrofurantoin 50 mg normal-release every 6 h (NF50) and nitrofurantoin 100 mg extended-release every 12 h (NF100) are equally effective for treating cystitis in primary care. In the Netherlands, GP prescription of either option largely depends on pharmacy procureme...

Descripción completa

Detalles Bibliográficos
Autores principales:	ten Doesschate, Thijs, Groenwold, Rolf H H, Bonten, Marc J M, van Werkhoven, Cornelis H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798831/ https://www.ncbi.nlm.nih.gov/pubmed/31504584 http://dx.doi.org/10.1093/jac/dkz350

Ejemplares similares

Nitrofurantoin failure in males with an uncomplicated urinary tract infection: a primary care observational cohort study
por: Platteel, Tamara N, et al.
Publicado: (2023)

1692. Retrospective Review on the Safety and Efficacy of Nitrofurantoin for the Treatment of Cystitis in the Veteran Population With or Without Renal Insufficiency
por: Welch, Elwyn W, et al.
Publicado: (2020)

Fosfomycin versus Nitrofurantoin for the Treatment of Lower UTI in Outpatients
por: Sharma, Shraddha, et al.
Publicado: (2021)

Nitrofurantoin methanol monosolvate
por: Vangala, Venu R., et al.
Publicado: (2011)

Reproductive toxicology. Nitrofurantoin.
Publicado: (1997)

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)
por: ten Doesschate, Thijs, et al.
Publicado: (2018)

Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018)

Relapsing nitrofurantoin-induced pneumonitis
por: Turner, Richard D., et al.
Publicado: (2011)

Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias
por: van der Vaart, Thomas W, et al.
Publicado: (2023)

Nitrofurantoin‐induced acute pulmonary toxicity
por: Livanios, Konstantinos, et al.
Publicado: (2016)

Nitrofurantoin induced interstitial lung disease
por: Naidu, G. D., et al.
Publicado: (2014)

Nitrofurantoin-induced radiation recall dermatitis
por: Garrahy, Ian, et al.
Publicado: (2019)

Interstitial Lung Disease Secondary to Long-Term Nitrofurantoin Use
por: Chin, Andrew J., et al.
Publicado: (2020)

In Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis
por: Yeo, Seon-Ju, et al.
Publicado: (2016)

Consider Nitrofurantoin as a Cause of Lung Injury
por: Almeida, Paulo, et al.
Publicado: (2019)

Molecular mechanisms of collateral sensitivity to the antibiotic nitrofurantoin
por: Roemhild, Roderich, et al.
Publicado: (2020)

Assessment of Nitrofurantoin as an Experimental Intracanal Medicament in Endodontics
por: Alrahman, Mewan Salahalddin A., et al.
Publicado: (2020)

Systemic Inflammatory Response Syndrome Secondary to Nitrofurantoin
por: McGarry, Molly R., et al.
Publicado: (2021)

Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis
por: Anupama, B. K., et al.
Publicado: (2021)

Nitrofurantoin: Interstitial lung disease: case report
Publicado: (2021)

Nitrofurantoin: what is the evidence for current UK guidance?
por: Kashouris, Eleanor, et al.
Publicado: (2023)

Comparison of variance estimators for meta-analysis of instrumental variable estimates
por: Schmidt, AF, et al.
Publicado: (2016)

In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal flora
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

Correction to: Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials
por: ten Doesschate, Thijs, et al.
Publicado: (2020)

Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials
por: ten Doesschate, Thijs, et al.
Publicado: (2020)

Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial( )
por: ten Doesschate, Thijs, et al.
Publicado: (2021)

Synthesis, in vitro Antileishmanial Efficacy and Hit/Lead Identification of Nitrofurantoin‐Triazole Hybrids
por: Zuma, Nonkululeko H., et al.
Publicado: (2022)

Nitrofurantoin-induced pulmonary fibrosis: a case report
por: Goemaere, Natascha NT, et al.
Publicado: (2008)

Autoimmune hepatitis triggered by nitrofurantoin: a case series
por: Appleyard, Sally, et al.
Publicado: (2010)

Nitrofurantoin Toxicity: A Near Case of Mistaken Identity
por: Miskoff, Jeffrey A, et al.
Publicado: (2018)

Nitrofurantoin—Microbial Degradation and Interactions with Environmental Bacterial Strains
por: Pacholak, Amanda, et al.
Publicado: (2019)

In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs
por: Munsimbwe, Linous, et al.
Publicado: (2021)

Drug-induced haemolysis: another reason to be cautious with nitrofurantoin
por: Bhatt, Chaitanya, et al.
Publicado: (2023)

Nitrofurantoin-Induced Exfoliative Dermatitis: A Case Report
por: Morna, Carolina, et al.
Publicado: (2022)

O02 Nitrofurantoin: what is the evidence for current guidance?
por: Kashouris, Eleanor, et al.
Publicado: (2023)

Emphysematous cystitis.
por: Lee, G., et al.
Publicado: (1998)

Selection of confounding variables should not be based on observed associations with exposure
por: Groenwold, Rolf H. H., et al.
Publicado: (2011)

BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial
por: Claus, Juana, et al.
Publicado: (2023)

An assessment of the role of redox cycling in mediating the toxicity of paraquat and nitrofurantoin.
por: Adam, A, et al.
Publicado: (1990)

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin
por: Singh, Jitendra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mgud530qihepi09h4e868p4tbp